Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.64 |
| ▸ | MAOB | P27338 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31237248 | 1.00 | MAOA (0.64) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| SCHEMBL29473025 | 0.95 | MAOA (0.64) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| SCHEMBL27182861 | 0.88 | CYP3A4 (0.58) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| Medicarpin SCHEMBL2812444 | 0.83 | MAOA (0.78) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| Demethylmedicarpin SCHEMBL29843376 | 0.83 | MAOA (0.78) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| Demethylmedicarpin SCHEMBL31663447 | 0.83 | MAOA (0.78) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| SCHEMBL19999732 | 0.82 | MAPT (0.70) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| SCHEMBL12912390 | 0.82 | MAPT (0.70) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| SCHEMBL31039664 | 0.82 | MAPT (0.70) | MAOAMAOBCYP3A4MAPTMAPK1 | |
| SCHEMBL72476 | 0.82 | MAPT (0.70) | MAOAMAOBCYP3A4MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190216707-A1 | COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH, COMPRISING PHYTOESTROGEN AS AN ACTIVE INGREDIENT | STEMORE CO., LTD. (KR) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190216707-A1 | COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH, COMPRISING PHYTOESTROGEN AS AN ACTIVE INGREDIENT | SHBG, CYP19A1, HSD17B11 | MAOA 211/4885MAOB 278/4885CYP3A4 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.